C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,739 | -70,702 | -34,780 | -128,175 | -90,990 |
| Depreciation Amortization | -962 | -367 | 75 | 3,103 | 2,807 |
| Accounts receivable | 973 | 445 | 945 | 4,244 | 4,229 |
| Accounts payable and accrued liabilities | 104 | 941 | -138 | -3,333 | -2,257 |
| Other Working Capital | -10,341 | 3,155 | -6,220 | -16,779 | -16,119 |
| Other Operating Activity | 25,136 | 14,406 | 6,993 | 35,001 | 25,519 |
| Operating Cash Flow | $-82,829 | $-52,122 | $-33,125 | $-105,939 | $-76,811 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -92,020 | -60,078 | -11,437 | -219,527 | -163,238 |
| PPE Investments | -1,551 | -951 | -589 | -5,496 | -4,006 |
| Sale Of Investment | 219,975 | 129,708 | 65,557 | 283,445 | 216,382 |
| Investing Cash Flow | $126,404 | $68,679 | $53,531 | $58,422 | $49,138 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -12,500 | -1,500 | -750 | N/A | 0 |
| Common Stock Issued | 58 | 58 | 56 | 777 | 730 |
| Common Stock Repurchased | -110 | -94 | -94 | N/A | N/A |
| Other Financing Activity | 369 | 106 | 104 | 370 | 370 |
| Financing Cash Flow | $-12,183 | $-1,430 | $-684 | $1,147 | $1,100 |
| Beginning Cash Position | 33,033 | 33,033 | 33,033 | 79,403 | 79,403 |
| End Cash Position | 64,425 | 48,160 | 52,755 | 33,033 | 52,830 |
| Net Cash Flow | $31,392 | $15,127 | $19,722 | $-46,370 | $-26,573 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,829 | -52,122 | -33,125 | -105,939 | -76,811 |
| Capital Expenditure | -1,551 | -951 | -589 | -5,496 | -4,006 |
| Free Cash Flow | -84,380 | -53,073 | -33,714 | -111,435 | -80,817 |